Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study
Song, Yuqin, Gao, Quanli, Zhang, Huilai, Fan, Lei, Zhou, Jianfeng, Zou, Dehui, Li, Wei, Yang, Haiyan, Liu, Ting, Wang, Quanshun, Lv, Fangfang, Guo, Haiyi, Yang, Liudi, Elstrom, Rebecca, Huang, Jane, NJournal:
Leukemia
DOI:
10.1038/s41375-019-0545-2
Date:
September, 2019
File:
PDF, 551 KB
2019
File converter
More search results
More benefits 
